全文获取类型
收费全文 | 14976篇 |
免费 | 967篇 |
国内免费 | 95篇 |
专业分类
耳鼻咽喉 | 131篇 |
儿科学 | 326篇 |
妇产科学 | 876篇 |
基础医学 | 1909篇 |
口腔科学 | 316篇 |
临床医学 | 1694篇 |
内科学 | 3159篇 |
皮肤病学 | 281篇 |
神经病学 | 1146篇 |
特种医学 | 428篇 |
外科学 | 1992篇 |
综合类 | 304篇 |
一般理论 | 8篇 |
预防医学 | 791篇 |
眼科学 | 424篇 |
药学 | 1081篇 |
中国医学 | 126篇 |
肿瘤学 | 1046篇 |
出版年
2023年 | 56篇 |
2022年 | 155篇 |
2021年 | 358篇 |
2020年 | 155篇 |
2019年 | 310篇 |
2018年 | 417篇 |
2017年 | 252篇 |
2016年 | 284篇 |
2015年 | 448篇 |
2014年 | 540篇 |
2013年 | 757篇 |
2012年 | 1102篇 |
2011年 | 1172篇 |
2010年 | 751篇 |
2009年 | 618篇 |
2008年 | 876篇 |
2007年 | 865篇 |
2006年 | 829篇 |
2005年 | 799篇 |
2004年 | 726篇 |
2003年 | 636篇 |
2002年 | 610篇 |
2001年 | 552篇 |
2000年 | 532篇 |
1999年 | 378篇 |
1998年 | 115篇 |
1997年 | 108篇 |
1996年 | 100篇 |
1995年 | 79篇 |
1994年 | 73篇 |
1993年 | 68篇 |
1992年 | 187篇 |
1991年 | 155篇 |
1990年 | 116篇 |
1989年 | 115篇 |
1988年 | 107篇 |
1987年 | 83篇 |
1986年 | 73篇 |
1985年 | 64篇 |
1984年 | 47篇 |
1983年 | 32篇 |
1982年 | 26篇 |
1981年 | 26篇 |
1980年 | 19篇 |
1979年 | 42篇 |
1978年 | 24篇 |
1977年 | 24篇 |
1976年 | 20篇 |
1975年 | 25篇 |
1973年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
201.
202.
203.
Ya-Wen Lu Yi-Lin Tsai Ruey-Hsing Chou Chin-Sung Kuo Chun-Chin Chang Po-Hsun Huang Shing-Jong Lin 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2021,31(5):1509-1515
Background & aimsSarcopenia is a clinical syndrome that features muscle atrophy and weakness, and has been associated with cardiovascular events and poor clinical outcomes. Recently, the sarcopenia index (SI) was developed as a simple screening tool based upon the serum creatinine to cystatin C (CysC) ratio. We investigated the association between SI and the prevalence of major adverse cardiovascular events (MACE) in patients with obstructive CAD.Methods & ResultsBetween January 2010 and December 2018, patients with angina pectoris and obstructive CAD requiring coronary artery intervention were enrolled. Serum levels of CysC and other biomarkers were assessed. Patients were divided into two groups according to the SI ([Cr/CysC] x 100). Demographic characteristics and clinical outcomes of the two groups were evaluated. A total of 427 patients (79.6% men, mean age 69.55 ± 12.04 years) were enrolled. Patients with SI < 120 (n = 214, 28%) were older, more likely to be of the female gender, and to have more hypertension and congestive heart failure (all p < 0.05). The prevalence of major adverse cardiovascular events (MACE) composed of myocardial infarction, stroke, and all-cause mortality was higher in patients with lower SI (p = 0.026). After adjusting for potential confounding factors, multivariate Cox regression (hazard ratio 2.08, p = 0.045) and Kaplan–Meier analyses (log-rank p = 0.0371) revealed that lower SI was significantly associated with a higher prevalence of MACE.ConclusionsSerum creatinine to cystatin C ratio (SI) may be a useful surrogate marker to predict the future prevalence of MACE in patients with obstructive CAD. 相似文献
204.
Yen-Kuang Tai Cgek-Siung Wu Ching-Yang Tsai 《Journal of the Chinese Medical Association》2012,75(10):539-542
Any condition that shortens erythrocyte lifespan or decreases mean erythrocyte age may falsely lower hemoglobin A1c (A1C) test results. Ribavirin (RBV) used for chronic hepatitis C virus (HCV) infection can cause reversible hemolytic anemia; erythropoietin (EPO) used for treatment-related anemia can stimulate the production of red blood cells. We reported a 55-year-old woman with diabetes who received peginterferon alfa plus RBV for HCV infection. Four weeks following HCV therapy, her Hb level declined from 13.3 g/dL to 11.3 g/dL with elevated lactate dehydrogenase and reduced haptoglobin, which confirmed hemolysis. As her Hb fell to a nadir of 8.5 g/dL at the eighth week, darbepoetin alfa was administered to treat anemia consecutively for 10 weeks. Two months later, the patient's A1C declined from 7.5% to an extremely low value of 4.0%, accompanied by a fasting glucose level of 116 mg/dL. During the preceding 3 months, there was no self-reported hypoglycemia or documented low blood glucose. About 3 months after HCV therapy was terminated, the A1C returned to 6.1% without medication adjustment. The concurrent use of RBV and EPO treatments can synergistically cause falsely low A1C values and may lead to inappropriate relaxation of glycemic control. During HCV treatment with RBV, A1C should not be used alone to guide diabetes therapy. 相似文献
205.
206.
207.
Maneesha Bhaya M.D. Ferit Onur Mutluer M.D. Edward Mahan M.D. Luke Mahan Ming C. Hsiung M.D. Wei–Hsian Yin M.D. Ph.D. Jeng Wei M.D. MsD Shen–Kou Tsai M.D. Ph.D. Guang–Yu Zhao M.D. Wei–Hsian Yin M.D. Manish Pradhan M.D. Rajesh Beniwal M.D. Deepak Joshi M.D. Fatemeh Nabavizadeh M.D. Amitoj Singh M.B.B.S. Navin C. Nanda M.D. 《Echocardiography (Mount Kisco, N.Y.)》2013,30(3):345-353
208.
Jia‐Huei Tsai Wen‐Chih Huang Kuan‐Ting Kuo Ray‐Hwang Yuan Yu‐Ling Chen Yung‐Ming Jeng 《Histopathology》2012,61(6):1106-1116
Tsai J‐H, Huang W‐C, Kuo K‐T, Yuan R‐H, Chen Y‐L & Jeng Y‐M (2012) Histopathology S100P immunostaining identifies a subset of peripheral‐type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas Aims: S100P is a calcium‐binding protein that is frequently expressed in pancreatic adenocarcinoma and perihilar cholangiocarcinoma. The aim of this study was to investigate the pathological significance of the expression of S100P in peripheral intrahepatic cholangiocarcinoma (ICC). Methods and results: Immunohistochemical staining was used to investigate S100P expression in 112 cases of peripheral ICC. The results were compared with those for perihilar and extrahepatic cholangiocarcinomas. Patients with S100P‐positive peripheral ICC were more likely to have elevated serum levels of carcinoembryonic antigen (CEA) and CA19‐9 than those with S100P‐negative peripheral ICCs. All cases of peripheral ICC associated with intrahepatic lithiasis and all cases with intraductal/periductal growth patterns were positive for S100P. S100P‐positive peripheral ICCs were highly associated with ‘bile duct’ morphology rather than cholangiolar differentiation. Nearly all cases of perihilar and extrahepatic cholangiocarcinoma were positive for S100P. Similarly to perihilar and extrahepatic cholangiocarcinomas, S100P‐positive peripheral ICCs showed more frequent expression of CEA and MUC2, and were more likely to be N‐cadherin‐negative, than S100P‐negative cases. Notably, K‐RAS mutations were only detected in S100P‐positive peripheral ICCs, with a frequency similar to that in perihilar and extrahepatic cholangiocarcinomas. Patients with S100P‐positive peripheral ICC were more likely to have poor prognoses than those with S100P‐negative tumours. Conclusions: S100P immunostaining identifies a subset of peripheral ICC that probably originates from larger bile ducts. This subset of peripheral ICCs shares common morphological and molecular features with perihilar and extrahepatic cholangiocarcinomas. 相似文献
209.
210.